Results: 1-19 |
Results: 19

Authors: Evans, TG McElrath, MJ Matthews, T Montefiori, D Weinhold, K Wolff, M Keefer, MC Kallas, EG Corey, L Gorse, GJ Belshe, R Graham, BS Spearman, PW Schwartz, D Mulligan, MJ Goepfert, P Fast, P Berman, P Powell, M Francis, D
Citation: Tg. Evans et al., QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans, VACCINE, 19(15-16), 2001, pp. 2080-2091

Authors: Schmechel, SC Russell, N Hladik, F Lang, J Wilson, A Ha, R Desbien, A McElrath, MJ
Citation: Sc. Schmechel et al., Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons, IMMUNOL LET, 79(1-2), 2001, pp. 21-27

Authors: Ferrari, G Neal, W Jones, A Olender, N Ottinger, J Ha, R McElrath, MJ Goepfert, P Weinhold, KJ
Citation: G. Ferrari et al., CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition, IMMUNOL LET, 79(1-2), 2001, pp. 37-45

Authors: White, HD Musey, LK Andrews, MM Yeaman, GR DeMars, LR Manganiello, PD Howell, AL Wira, CR Green, WR McElrath, MJ
Citation: Hd. White et al., Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: Lack of correlation between mucosa and peripheral blood, J INFEC DIS, 183(6), 2001, pp. 977-983

Authors: Hladik, F Bender, S Akridge, RE Hu, YX Galloway, C Francis, D McElrath, MJ
Citation: F. Hladik et al., Recombinant HIV-1 glycoprotein 120 induces distinct types of delayed hypersensitivity in persons with or without pre-existing immunologic memory, J IMMUNOL, 166(5), 2001, pp. 3580-3588

Authors: Malhotra, U Holte, S Dutta, S Berrey, MM Delpit, E Koelle, DM Sette, A Corey, L McElrath, MJ
Citation: U. Malhotra et al., Role for HLA class II molecules in HIV-1 suppression and cellular immunityfollowing antiretroviral treatment, J CLIN INV, 107(4), 2001, pp. 505-517

Authors: McElrath, MJ Corey, L Montefiori, D Wolff, M Schwartz, D Keefer, M Belshe, R Graham, BS Matthews, T Wright, P Gorse, G Dolin, R Berman, P Francis, D Duliege, AM Bolognesi, D Stablein, D Ketter, N Fast, P
Citation: Mj. Mcelrath et al., A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection, AIDS RES H, 16(9), 2000, pp. 907-919

Authors: Schooley, RT Spino, C Kuritzkes, D Walker, BD Valentine, FT Hirsch, MS Cooney, E Friedland, G Kundu, S Merigan, TC McElrath, MJ Collier, A Plaeger, S Mitsuyasu, R Kahn, J Haslett, P Uherova, P deGruttola, V Chiu, S Zhang, B Jones, G Bell, D Ketter, N Twadell, T Chernoff, D Rosandich, M
Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364

Authors: Malhotra, U Berrey, MM Huang, YJ Markee, J Brown, DJ Ap, S Musey, L Schacker, T Corey, L McElrath, MJ
Citation: U. Malhotra et al., Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection, J INFEC DIS, 181(1), 2000, pp. 121-131

Authors: Gorse, GJ Corey, L Patel, GB Mandava, M Hsieh, RH Matthews, TJ Walker, MC McElrath, MJ Berman, PW Eibl, MM Belshe, RB
Citation: Gj. Gorse et al., HIV-1(MN) recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1(MN) recombinant glycoprotein 120 vaccine, AIDS RES H, 15(2), 1999, pp. 115-132

Authors: Akridge, R Hladik, F Markee, J Alef, C Kelley, H Collier, A McElrath, MJ
Citation: R. Akridge et al., Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure, IMMUNOL LET, 66(1-3), 1999, pp. 15-19

Authors: Hladik, F Lentz, G Akridge, RE Peterson, G Kelley, H McElroy, A McElrath, MJ
Citation: F. Hladik et al., Dendritic cell-T-cell interactions support coreceptor-independent human immunodeficiency virus type 1 transmission in the human genital tract, J VIROLOGY, 73(7), 1999, pp. 5833-5842

Authors: Wright, PF Lambert, JS Gorse, GJ Hsieh, RH McElrath, MJ Weinhold, K Wara, DW Anderson, EL Keefer, MC Jackson, S Wagner, LJ Francis, DP Fast, PE McNamara, J
Citation: Pf. Wright et al., Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women, J INFEC DIS, 180(4), 1999, pp. 1080-1088

Authors: McElrath, MJ
Citation: Mj. Mcelrath, Cytotoxic T lymphocyte precursors in persons with repeated exposure to human immunodeficiency virus - Reply, J INFEC DIS, 180(4), 1999, pp. 1406-1407

Authors: Musey, LK Krieger, JN Hughes, JP Schacker, T Corey, L McElrath, MJ
Citation: Lk. Musey et al., Early and persistent human immunodeficiency virus type 1 (HIV-l)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection, J INFEC DIS, 180(2), 1999, pp. 278-284

Authors: Evans, TG Keefer, MC Weinhold, KJ Wolff, M Montefiori, D Gorse, GJ Graham, BS McElrath, MJ Clements-Mann, ML Mulligan, MJ Fast, P Walker, MC Excler, JL Duliege, AM Tartaglia, J
Citation: Tg. Evans et al., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers, J INFEC DIS, 180(2), 1999, pp. 290-298

Authors: Goh, WC Markee, J Akridge, RE Meldorf, M Musey, L Karchmer, T Krone, M Collier, A Corey, L Emerman, M McElrath, MJ
Citation: Wc. Goh et al., Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects, J INFEC DIS, 179(3), 1999, pp. 548-557

Authors: Hladik, F Lentz, G Delpit, E McElroy, A McElrath, MJ
Citation: F. Hladik et al., Coexpression of CCR5 and IL-2 in human genital but not blood T cells: Implications for the ontogeny of the CCR5(+) Th1 phenotype, J IMMUNOL, 163(4), 1999, pp. 2306-2313

Authors: Sheon, AR Wagner, L McElrath, MJ Keefer, MC Zimmerman, E Israel, H Berger, D Fast, P
Citation: Ar. Sheon et al., Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial, J ACQ IMM D, 19(5), 1998, pp. 519-526
Risultati: 1-19 |